Company profile
NRG Therapeutics
Advancing a pipeline of first-in-class oral small molecule mPTP inhibitors as treatments for neurodegenerative diseases
- Industry
- Biotechnology Research
- Employees
- 23
- Headquarters
- Stevenage, Hertfordshire
- LinkedIn followers
- 4,329
- Office locations
- 1
NRG Therapeutics company summary
NRG Therapeutics is a company in the Biotechnology Research industry, headquartered in Stevenage, Hertfordshire. On LinkedIn the company has around 23 employees and 4,329 followers. Its listed specialties include neuroscience.
What technology does NRG Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NRG Therapeutics
NRG Therapeutics is a clinical stage neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) and Parkinson’s. The company’s pipeline of first-in-class small molecule assets is based on inhibiting the mitochondrial permeability transition pore (mPTP) through a novel mechanism of action. Inhibition of the mPTP has been shown to protect neurons, reduce neuroinflammation, and improve motor function in preclinical disease models. Its lead candidate NRG5051, is advancing through human clinical trials.
Specialties
Where is NRG Therapeutics located?
NRG Therapeutics lists 1 location.
Compare companies similar to NRG Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NRG Therapeutics nrgtherapeutics.com | Biotechnology Research | 23 | - | Stevenage, Hertfordshire |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about NRG Therapeutics
What does NRG Therapeutics do?
NRG Therapeutics is a clinical stage neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND) and Parkinson’s. The company’s pipeline of first-in-class small molecule assets is based on inhibiting the mitochondrial permeability transition pore (mPTP) through a novel mechanism of action. Inhibition of the mPTP has been shown to protect neurons, reduce neuroinflammation, and improve motor function in preclinical disease models. Its lead candidate NRG5051, is advancing through human clinical trials.
How many employees does NRG Therapeutics have?
NRG Therapeutics has around 23 employees on LinkedIn.
Where is NRG Therapeutics headquartered?
NRG Therapeutics is headquartered in Stevenage, Hertfordshire.
Build a lead list from companies like NRG Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.